RSS feed

Publications (original articles or review articles) published in 2023 from OUS - Section for Cancer Cytogenetics

13 publications found

Blakstad H, Brekke J, Rahman MA, Arnesen VS, Miletic H, Brandal P, Lie SA, Chekenya M, Goplen D (2023)
Survival in a consecutive series of 467 glioblastoma patients: Association with prognostic factors and treatment at recurrence at two independent institutions
PLoS One, 18 (2), e0281166
DOI 10.1371/journal.pone.0281166, PubMed 36730349

Blakstad H, Mendoza Mireles EE, Heggebø LC, Magelssen H, Sprauten M, Johannesen TB, Vik-Mo EO, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Brandal P (2023)
Incidence and outcome of pseudoprogression after radiation therapy in glioblastoma patients: A cohort study
Neurooncol Pract, 11 (1), 36-45
DOI 10.1093/nop/npad063, PubMed 38222046

Boye K, Gorunova L, Gunawan B, Hompland I, Sander B, Panagopoulos I, Langer C, Golas M, Heim S, Füzesi L, Hølmebakk T, Micci F (2023)
Genomic Complexity as a Biomarker to De-Escalate Adjuvant Imatinib Treatment in High-Risk Gastrointestinal Stromal Tumor
JCO Precis Oncol, 7, e2200351
DOI 10.1200/PO.22.00351, PubMed 36724411

Kalmbach S, Grau M, Zapukhlyak M, Leich E, Jurinovic V, Hoster E, Staiger AM, Kurz KS, Weigert O, Gaitzsch E, Passerini V, Engelhard M, Herfarth K, Beiske K, Micci F, Möller P, Bernd HW, Feller AC, Klapper W, Stein H, Hansmann ML, Hartmann S, Dreyling M, Holte H, Lenz G et al. (2023)
Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms
Leukemia, 37 (10), 2058-2065
DOI 10.1038/s41375-023-01995-w, PubMed 37563306

Norén-Nyström U, Andersen MK, Barbany G, Dirse V, Eilert-Olsen M, Engvall M, Harila-Saari A, Heyman M, Hovland R, Häikiö S, Jónsson JJ, Karhu R, Kjeldsen E, Norberg A, Preiss BS, Pulkkinen K, Quist-Paulsen P, Räsänen H, Schmiegelow K, Seitsonen A, Sjögren H, Tammur P, Johansson B (2023)
Genetic Subtypes and Outcome of Patients Aged 1 to 45 Years Old With Acute Lymphoblastic Leukemia in the NOPHO ALL2008 Trial
Hemasphere, 7 (5), e883
DOI 10.1097/HS9.0000000000000883, PubMed 37153872

Panagopoulos I, Andersen K, Brunetti M, Gorunova L, Davidson B, Lund-Iversen M, Micci F, Heim S (2023)
Genetic Pathways in Peritoneal Mesothelioma Tumorigenesis
Cancer Genomics Proteomics, 20 (4), 363-374
DOI 10.21873/cgp.20388, PubMed 37400148

Panagopoulos I, Andersen K, Brunetti M, Gorunova L, Kostolomov I, Kildal W, Hognestad HR, Lobmaier I, Micci F, Heim S (2023)
Pathogenetic Dichotomy in Angioleiomyoma
Cancer Genomics Proteomics, 20 (6), 556-566
DOI 10.21873/cgp.20405, PubMed 37889065

Panagopoulos I, Andersen K, Brunetti M, Gorunova L, Lund-Iversen M, Micci F, Heim S (2023)
Fusion of the High-mobility Group AT-Hook 2 (HMGA2) and the Gelsolin (GSN) Genes in Lipomas With t(9;12)(q33;q14) Chromosomal Translocation
In Vivo, 37 (2), 524-530
DOI 10.21873/invivo.13110, PubMed 36881074

Panagopoulos I, Andersen K, Gorunova L, Hognestad HR, Pedersen TD, Lobmaier I, Micci F, Heim S (2023)
Chromosome Translocation t(10;19)(q26;q13) in a CIC-sarcoma
In Vivo, 37 (1), 57-69
DOI 10.21873/invivo.13054, PubMed 36593014

Panagopoulos I, Andersen K, Gorunova L, Lund-Iversen M, Lobmaier I, Micci F, Heim S (2023)
Recurrent 8q11-13 Aberrations Leading to PLAG1 Rearrangements, Including Novel Chimeras HNRNPA2B1::PLAG1 and SDCBP::PLAG1, in Lipomatous Tumors
Cancer Genomics Proteomics, 20 (2), 171-181
DOI 10.21873/cgp.20372, PubMed 36870688

Panagopoulos I, Andersen K, Rinvoll Johannsdottir IM, Micci F, Heim S (2023)
Novel MYCBP::EHD2 and RUNX1::ZNF780A Fusion Genes in T-cell Acute Lymphoblastic Leukemia
Cancer Genomics Proteomics, 20 (1), 51-63
DOI 10.21873/cgp.20364, PubMed 36581344

Panagopoulos I, Andersen K, Wik HS, Tandsæther MR, Micci F, Heim S (2023)
Acute Undifferentiated Leukemia With a Balanced t(5;10)(q35;p12) Resulting in Fusion of HNRNPH1 With MLLT10
Cancer Genomics Proteomics, 20 (4), 354-362
DOI 10.21873/cgp.20387, PubMed 37400142

Panagopoulos I, Gorunova L, Lobmaier I, Heim S (2023)
Fusion of the Genes for Interferon Regulatory Factor 2 Binding Protein 2 (IRF2BP2) and Caudal Type Homeobox 1 (CDX1) in a Chondrogenic Tumor
In Vivo, 37 (6), 2459-2463
DOI 10.21873/invivo.13352, PubMed 37905608